Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-08-007213
Filing Date
2008-04-24
Accepted
2008-04-23 20:52:43
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K v37725a2e10vkza.htm 10-K/A 42413
2 EXHIBIT 31.1 v37725a2exv31w1.htm EX-31.1 6408
3 EXHIBIT 31.2 v37725a2exv31w2.htm EX-31.2 6391
4 EXHIBIT 32.1 v37725a2exv32w1.htm EX-32.1 3537
5 EXHIBIT 32.2 v37725a2exv32w2.htm EX-32.2 3533
  Complete submission text file 0000950134-08-007213.txt   63825
Mailing Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004
Business Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004 425-450-0370
Oncothyreon Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33882 | Film No.: 08772876
SIC: 8731 Services-Commercial Physical & Biological Research